158 related articles for article (PubMed ID: 10408702)
21. Anti-angiogenic and apoptotic effects of metabolites of sulindac on chick embryo chorioallantoic membrane.
Elwich-Flis S; Sołtysiak-Pawluczuk D; Spławiński J
Hybrid Hybridomics; 2003 Feb; 22(1):55-60. PubMed ID: 12713691
[TBL] [Abstract][Full Text] [Related]
22. Antitumor effects of thalidomide analogs in human prostate cancer xenografts implanted in immunodeficient mice.
Ng SS; MacPherson GR; Gütschow M; Eger K; Figg WD
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4192-7. PubMed ID: 15217957
[TBL] [Abstract][Full Text] [Related]
23. Selective cytokine inhibitory drugs with enhanced antiangiogenic activity control tumor growth through vascular inhibition.
Gee MS; Makonnen S; al-Kofahi K; Roysam B; Payvandi F; Man HW; Muller GW; Lee WM
Cancer Res; 2003 Dec; 63(23):8073-8. PubMed ID: 14678955
[TBL] [Abstract][Full Text] [Related]
24. The inhibitory effect of thalidomide analogue on corneal neovascularization in rabbits.
Lee YK; Chung SK
Cornea; 2013 Aug; 32(8):1142-8. PubMed ID: 23739149
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of antiangiogenic compounds in neovascularization, leukocyte recruitment, VEGF production, and tumor growth in mice.
Belo AV; Barcelos LS; Teixeira MM; Ferreira MA; Andrade SP
Cancer Invest; 2004; 22(5):723-9. PubMed ID: 15581054
[TBL] [Abstract][Full Text] [Related]
26. Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells.
Ciardiello F; Bianco R; Damiano V; Fontanini G; Caputo R; Pomatico G; De Placido S; Bianco AR; Mendelsohn J; Tortora G
Clin Cancer Res; 2000 Sep; 6(9):3739-47. PubMed ID: 10999768
[TBL] [Abstract][Full Text] [Related]
27. Failure of thalidomide to inhibit tumor growth and angiogenesis in vivo.
Gutman M; Szold A; Ravid A; Lazauskas T; Merimsky O; Klausner JM
Anticancer Res; 1996; 16(6B):3673-7. PubMed ID: 9042240
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of corneal neovascularization by rapamycin.
Kwon YS; Kim JC
Exp Mol Med; 2006 Apr; 38(2):173-9. PubMed ID: 16672771
[TBL] [Abstract][Full Text] [Related]
29. Combination of tumor necrosis factor-alpha with sulindac augments its apoptotic potential and suppresses tumor growth of human carcinoma cells in nude mice.
Yasui H; Adachi M; Imai K
Cancer; 2003 Mar; 97(6):1412-20. PubMed ID: 12627504
[TBL] [Abstract][Full Text] [Related]
30. Combination of thalidomide and cisplatin in an head and neck squamous cell carcinomas model results in an enhanced antiangiogenic activity in vitro and in vivo.
Vasvari GP; Dyckhoff G; Kashfi F; Lemke B; Lohr J; Helmke BM; Schirrmacher V; Plinkert PK; Beckhove P; Herold-Mende CC
Int J Cancer; 2007 Oct; 121(8):1697-704. PubMed ID: 17557286
[TBL] [Abstract][Full Text] [Related]
31. Circulating angiogenic growth factor levels in mice bearing human tumors using Luminex Multiplex technology.
Keyes KA; Mann L; Cox K; Treadway P; Iversen P; Chen YF; Teicher BA
Cancer Chemother Pharmacol; 2003 Apr; 51(4):321-7. PubMed ID: 12721760
[TBL] [Abstract][Full Text] [Related]
32. Role of vascular endothelial growth factor in angiodysplasia: an interventional study with thalidomide.
Tan H; Chen H; Xu C; Ge Z; Gao Y; Fang J; Liu W; Xiao S
J Gastroenterol Hepatol; 2012 Jun; 27(6):1094-101. PubMed ID: 22098296
[TBL] [Abstract][Full Text] [Related]
33. Combination therapy with paclitaxel and thalidomide inhibits angiogenesis and growth of human colon cancer xenograft in mice.
Fujii T; Tachibana M; Dhar DK; Ueda S; Kinugasa S; Yoshimura H; Kohno H; Nagasue N
Anticancer Res; 2003; 23(3B):2405-11. PubMed ID: 12894521
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of angiogenesis by adenovirus-mediated sFlt-1 expression in a rat model of corneal neovascularization.
Lai CM; Brankov M; Zaknich T; Lai YK; Shen WY; Constable IJ; Kovesdi I; Rakoczy PE
Hum Gene Ther; 2001 Jul; 12(10):1299-310. PubMed ID: 11440623
[TBL] [Abstract][Full Text] [Related]
35. A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma.
Rajkumar SV; Witzig TE
Cancer Treat Rev; 2000 Oct; 26(5):351-62. PubMed ID: 11006136
[TBL] [Abstract][Full Text] [Related]
36. The effect of subconjunctival suramin on corneal neovascularization in rabbits.
Lee HS; Chung SK
Cornea; 2010 Jan; 29(1):86-92. PubMed ID: 19907290
[TBL] [Abstract][Full Text] [Related]
37. Combination treatment with temozolomide and thalidomide inhibits tumor growth and angiogenesis in an orthotopic glioma model.
Son MJ; Kim JS; Kim MH; Song HS; Kim JT; Kim H; Shin T; Jeon HJ; Lee DS; Park SY; Kim YJ; Kim JH; Nam DH
Int J Oncol; 2006 Jan; 28(1):53-9. PubMed ID: 16327979
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of herbal remedy PERVIVO and anti-inflammatory drug sulindac on L-1 sarcoma tumor growth and tumor angiogenesis in Balb/c mice.
Skopiński P; Bałan BJ; Kocik J; Zdanowski R; Lewicki S; Niemcewicz M; Gawrychowski K; Skopińska-Różewska E; Stankiewicz W
Mediators Inflamm; 2013; 2013():289789. PubMed ID: 23935247
[TBL] [Abstract][Full Text] [Related]
39. Antiangiogenic activity of beta-eudesmol in vitro and in vivo.
Tsuneki H; Ma EL; Kobayashi S; Sekizaki N; Maekawa K; Sasaoka T; Wang MW; Kimura I
Eur J Pharmacol; 2005 Apr; 512(2-3):105-15. PubMed ID: 15840394
[TBL] [Abstract][Full Text] [Related]
40. Assessing the ability of the antiangiogenic and anticytokine agent thalidomide to modulate radiation-induced lung injury.
Anscher MS; Garst J; Marks LB; Larrier N; Dunphy F; Herndon JE; Clough R; Marino C; Vujaskovic Z; Zhou S; Dewhirst MW; Shafman TD; Crawford J
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):477-82. PubMed ID: 16904841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
